RYOAX Mutual Fund
RYOAX Mutual Fund
RYOAX Mutual Fund
Rydex Biotechnology Fund Class H
RYOAX Mutual Fund Overview
RYOAX Mutual Fund (Rydex Biotechnology Fund Class H) is managed by Rydex Funds with $5.7M in net assets. RYOAX expense ratio is 1.63%, holding 69 positions across sectors including Health Care. Inception date: 1998-04-01.
RYOAX performance shows a YTD return of 15.03%. The 1-year return is 47.06% and the 5-year return is 5.46%. RYOAX dividend yield stands at 14.06%, paid annually.
RYOAX top holdings include Abbvie Inc. (7.6%), Amgen Inc. (5.1%), Gilead Sciences Inc (4.7%), Vertex Pharmaceuticals Inc (4.0%), Regeneron Pharmaceuticals, Inc. (2.9%). Go to all RYOAX holdings, RYOAX sectors, or RYOAX dividends.
RYOAX can be compared against other funds. Use RYOAX overlap to find shared positions, or RYOAX vs another fund for a side-by-side view. RYOAX alternatives are available via the screener, along with tax-loss harvesting opportunities.